Aspirin 'resistance': Role of pre-existent platelet reactivity and correlation between tests

Frelinger, A, Linden, M, Tarnow, I, Barnard, M, Fox, M and Michelson, A 2008, 'Aspirin 'resistance': Role of pre-existent platelet reactivity and correlation between tests', Journal of Thrombosis and Haemostasis, vol. 6, no. 12, pp. 2035-2044.


Document type: Journal Article
Collection: Journal Articles

Title Aspirin 'resistance': Role of pre-existent platelet reactivity and correlation between tests
Author(s) Frelinger, A
Linden, M
Tarnow, I
Barnard, M
Fox, M
Michelson, A
Year 2008
Journal name Journal of Thrombosis and Haemostasis
Volume number 6
Issue number 12
Start page 2035
End page 2044
Total pages 10
Publisher Wiley-Blackwell Publishing Ltd.
Abstract Background: Aspirin 'resistance' is a widely used term for hyporesponsiveness to aspirin in a platelet function test. Serum thromboxane (TX) B2 is the most specific test of aspirin's effect on platelets. Objectives: (i) To examine the role of pre-existent platelet hyperreactivity in aspirin 'resistance'. (ii) To determine the correlation between aspirin resistance defined by serum TXB2 and other assays of platelet function. Methods: To enable pre-aspirin samples to be drawn, platelet function was measured in normal subjects (n = 165) before and after aspirin 81mg daily for sevendays. Results: The proportion of the post-aspirin platelet function predicted by the pre-aspirin platelet function was 28.3 ± 7.5% (mean ± asymptotic standard error) for serum TXB2, 39.3 ± 6.8% for urinary 11-dehydro TXB2, 4.4 ± 7.7% for arachidonic acid-induced platelet aggregation, 40.4 ± 7.1% for adenosine diphosphate-induced platelet aggregation, 26.3 ± 9.2% for the VerifyNow Aspirin Assay®, and 45.0 ± 10.9% for the TEG® PlateletMapping™ System with arachidonic acid. There was poor agreement between aspirin-resistant subjects identified by serum TXB2 vs. aspirin-resistant subjects identified by the other five assays, irrespective of whether the analysis was based on categorical or continuous variables. Platelet count correlated with pre-aspirin serum TXB2 and VerifyNow Aspirin Assay, but not with any post-aspirin platelet function test. Conclusions: (i) Aspirin 'resistance' (i.e. hyporesponsiveness to aspirin in a laboratory test) is in part unrelated to aspirin but is the result of underlying platelet hyperreactivity prior to the institution of aspirin therapy. (ii) Aspirin resistance defined by serum TXB2 shows a poor correlation with aspirin resistance defined by other commonly used assays.
Subject Clinical Sciences not elsewhere classified
DOI - identifier 10.1111/j.1538-7836.2008.03184.x
Copyright notice © 2008 International Society on Thrombosis and Haemostasis.
ISSN 1538-7933
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 63 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 63 times in Scopus Article | Citations
Altmetric details:
Access Statistics: 192 Abstract Views  -  Detailed Statistics
Created: Mon, 06 Dec 2010, 14:11:00 EST by Catalyst Administrator
© 2014 RMIT Research Repository • Powered by Fez SoftwareContact us